2 Top TSX Stocks to Buy Before They Jump Over $10

HEXO stock and Goodfood Market stock shouldn’t escape the eyes of growth investors. Both companies have long growth runways and bright futures. Buy them now before the prices jump over $10.

| More on:
stocks rising

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The TSX has an abundance of cheap but profitable investment options. Two names, HEXO (TSX:HEXO)(NYSE:HEXO) and Goodfood Market (TSX:FOOD), should be on the buy lists of growth investors today. Scoop them now before their prices jump over $10.

Savvy moves and strategic partnerships

HEXO could be on the verge of a breakout, given its 35.99% year-to-date gain in 2021. Analysts are bullish on the cannabis stock and forecast a return potential of 74.7%. The current share price of $4.95 could easily climb to $8.65 in 12 months.

Canadian and American cannabis producers are preparing and waiting for the federal legalization of marijuana in the United States. Once it happens, HEXO could garner a significant market share. In Canada, the $754.51 million company cemented its leadership position in the adult-use market.

In Q3 2021, HEXO expects to complete the $925 million acquisition of Redecan, Canada’s largest privately owned licensed producer. According to HEXO CEO and co-founder Sebastien St-Louis, the plan is to leverage the combined expertise in product development, manufacturing, and branding in Canada.

Truss CBD USA, a joint venture with Molson Coors Beverage Company, is HEXO’s ticket to the lucrative U.S. markets. Apart from Molson, HEXO forged a partnership with REQ. The leader in digital marketing and brand reputation will assist HEXO in expanding its U.S. footprint. REQ will also be actively involved in supporting the growth initiatives of Truss CBD USA.

Pandemic stock

The global pandemic pushed Goodfood Market into the limelight. Its stock had a spectacular run in 2020, rewarding investors with a 287% total return. The streak continued in 2021 but eventually lost momentum towards the end of Q1 2020. As of July 30, 2021, the share price is $9.83, or a year-to-date loss of 18.89%.

Goodfood reported record revenues in Q3 fiscal 2021 (quarter ended May 31, 2021). From $86.6 million in Q3 fiscal 2021, it increased 24% to $107.8 million. However, the $726.55 million company swung to a net loss of $2 billion compared to the $2.8 million net income in the same period last year.

The 89% increase in selling, general, and administrative expenses was the reason for the net loss. For the nine months ended May 31, 2021, revenue grew 49%, while net loss expanded by 51% to $8.7 million. Management explained that Goodfood’s strategy is to focus more on generating long-term value instead of short-term profitability. The ultimate goal is to become Canada’s leading online grocer.

Goodfood president and COO Neil Cuggy note the record 35% gross margin. He said the milestone was due to continued last-mile delivery optimization and improved operational effectiveness. It led to lower credits and incentives, supported by growing scale and additional investments in automation.

While some analysts say Goodfood is an oversold pandemic stock, they agree the company has a huge runway for growth. Expect management to build a grocery business that competitors would find hard to match. Base on analysts’ buy rating, the price could top $12 (+22%) or climb as high as $15 (+53%) in the next 12 months.

Bright futures

HEXO and Goodfood Market have bright futures. The cannabis producer is gearing up for marijuana legalization in the U.S. while cornering the markets in Canada. Meanwhile, the online grocery company builds economies of scale that will eventually lead to increased profitability.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends Goodfood Market Corp and HEXO Corp.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »